Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said on Wednesday.

South Brazil state signs with Chinese drug company a Covid-19 vaccine trial - MercoPress


Click here to READ THE FULL STORY.